Pancreatic Cancer, Gall Bladder Cancer, Liver Cancer

Like breast cancer, in these cancers also peritoneal spread is a marker of and associated with widespread disease and hence CRS and HIPEC is not an option. Occasionally, some patients have limited disease and have a very good response to chemotherapy. In these patients CRS and HIPEC may be given a try. The outcome may not be as favourable as with other cancers